BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 11104189)

  • 1. Linkage exclusion in French families with probable Parkinson' s disease.
    Farrer M; Destée T; Becquet E; Wavrant-De Vrièze F; Mouroux V; Richard F; Defebvre L; Lincoln S; Hardy J; Amouyel P; Chartier-Harlin MC
    Mov Disord; 2000 Nov; 15(6):1075-83. PubMed ID: 11104189
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetics of Parkinson's disease.
    Polymeropoulos MH
    Ann N Y Acad Sci; 2000; 920():28-32. PubMed ID: 11193165
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of alpha-synuclein, parkin, tau, and UCH-L1 in a Japanese family with autosomal dominant parkinsonism.
    Hasegawa K; Funayama M; Matsuura N; Furusawa H; Sakai F; Kowa H; Obata F
    Eur Neurol; 2001; 46(1):20-4. PubMed ID: 11455179
    [TBL] [Abstract][Full Text] [Related]  

  • 4. No pathogenic mutations in the beta-synuclein gene in Parkinson's disease.
    Lincoln S; Crook R; Chartier-Harlin MC; Gwinn-Hardy K; Baker M; Mouroux V; Richard F; Becquet E; Amouyel P; Destée A; Hardy J; Farrer M
    Neurosci Lett; 1999 Jul; 269(2):107-9. PubMed ID: 10430516
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of alpha-synuclein, parkin, and ubiquitin carboxy-terminal hydrolase L1 mRNA in human brain: genes associated with familial Parkinson's disease.
    Solano SM; Miller DW; Augood SJ; Young AB; Penney JB
    Ann Neurol; 2000 Feb; 47(2):201-10. PubMed ID: 10665491
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Molecular pathogenesis of familial Parkinson's disease].
    Kitada T; Mizuno Y
    Nihon Rinsho; 2000 Oct; 58(10):2016-21. PubMed ID: 11068440
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Parkinson's disease: what have we learned from the genes responsible for familial forms?].
    Corti O; Brice A
    Med Sci (Paris); 2003 May; 19(5):613-9. PubMed ID: 12836396
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Importance of familial Parkinson's disease and parkinsonism to the understanding of nigral degeneration in sporadic Parkinson's disease.
    Hattori N; Shimura H; Kubo S; Wang M; Shimizu N; Tanaka K; Mizuno Y
    J Neural Transm Suppl; 2000; (60):101-16. PubMed ID: 11205133
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetics of Parkinson's disease.
    Gasser T
    J Neurol; 2001 Oct; 248(10):833-40. PubMed ID: 11697518
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetics of Parkinson's disease and biochemical studies of implicated gene products.
    Lansbury PT; Brice A
    Curr Opin Cell Biol; 2002 Oct; 14(5):653-60. PubMed ID: 12231362
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overview of the genetics of parkinsonism.
    Gasser T
    Adv Neurol; 2003; 91():143-52. PubMed ID: 12442673
    [No Abstract]   [Full Text] [Related]  

  • 12. Complex interactions in Parkinson's disease: a two-phased approach.
    Maraganore DM; de Andrade M; Lesnick TG; Farrer MJ; Bower JH; Hardy JA; Rocca WA
    Mov Disord; 2003 Jun; 18(6):631-6. PubMed ID: 12784265
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Parkinson's disease: one biochemical pathway to fit all genes?
    Krüger R; Eberhardt O; Riess O; Schulz JB
    Trends Mol Med; 2002 May; 8(5):236-40. PubMed ID: 12067634
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetics of Parkinson's disease and biochemical studies of implicated gene products.
    Lansbury PT; Brice A
    Curr Opin Genet Dev; 2002 Jun; 12(3):299-306. PubMed ID: 12076673
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Parkin, alpha-synuclein and other molecular aspects of Parkinson's disease].
    Corti O; Brice A
    J Soc Biol; 2002; 196(1):95-10. PubMed ID: 12134640
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genome screen to identify susceptibility genes for Parkinson disease in a sample without parkin mutations.
    Pankratz N; Nichols WC; Uniacke SK; Halter C; Rudolph A; Shults C; Conneally PM; Foroud T;
    Am J Hum Genet; 2002 Jul; 71(1):124-35. PubMed ID: 12058349
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exclusion of genetic linkage to 4q21-23 and 17q21 in a family with Lewy body parkinsonism.
    Hardy J; Pérez-Tur J; Baker M; Farrer M; Crook R; Hutton M; Johnson WG; Gwinn K; Muenter M; Rocca WA; Maraganore D
    Am J Med Genet; 1998 Mar; 81(2):166-71. PubMed ID: 9613857
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetics of Parkinson's disease.
    Mizuno Y; Hattori N; Mori H
    Biomed Pharmacother; 1999 Apr; 53(3):109-16. PubMed ID: 10349506
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The UCH-L1 gene encodes two opposing enzymatic activities that affect alpha-synuclein degradation and Parkinson's disease susceptibility.
    Liu Y; Fallon L; Lashuel HA; Liu Z; Lansbury PT
    Cell; 2002 Oct; 111(2):209-18. PubMed ID: 12408865
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Genetics of Parkinson disease].
    Brassat D; Durr A; Agid Y; Brice A
    Rev Med Interne; 1999 Aug; 20(8):709-14. PubMed ID: 10480176
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.